D. Pittrow

H. Völzke, H. Wittchen, N. Friedrich, 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Update on endothelin‐related diseases

W. Kirch, D. Pittrow, 2009, European journal of clinical investigation.

Prevalence of low male testosterone levels in primary care in Germany: cross‐sectional results from the DETECT study

H. Wittchen, H. Lehnert, G. Stalla, 2008, Clinical endocrinology.

Associations of age-dependent IGF-I SDS with cardiovascular diseases and risk conditions: cross-sectional study in 6773 primary care patients.

S. Silber, W. März, H. Wittchen, 2008, European journal of endocrinology.

Low-grade albuminuria and cardiovascular risk : what is the evidence?

M. Böhm, R. Schmieder, U. Tebbe, 2007, Clinical research in cardiology : official journal of the German Cardiac Society.

Rationale, design, and methodology of the observational INSIGHTS-SVT study on the current state of care and outcomes of patients with superficial vein thrombosis.

J. Klotsche, D. Pittrow, U. Hoffmann, 2017, Journal of vascular surgery. Venous and lymphatic disorders.

Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

S. Rosenkranz, H. Ghofrani, M. Hoeper, 2017, European Respiratory Journal.

Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women.

D. Pittrow, C. Diehm, H. Trampisch, 2009, Current medical research and opinion.

Systemic sclerosis-associated pulmonary hypertension: why disease-specific composite endpoints are needed

M. Humbert, D. Furst, C. Denton, 2011, Arthritis research & therapy.

Incidence and characteristics of chronic thromboembolic pulmonary hypertension in Germany

H. Schäfers, M. Hoeper, K. Olsson, 2018, Clinical Research in Cardiology.

Advances in the treatment of pulmonary arterial hypertension: focus on endothelin receptor antagonism

D. Pittrow, W. Kirch, 2007 .

Dual endothelin receptor antagonism in pulmonary arterial hypertension

W. Kirch, D. Pittrow, 2006, European journal of clinical investigation.

Management of Patients With ST‐Segment Elevation or Non–ST‐Segment Elevation Acute Coronary Syndromes in Cardiac Rehabilitation Centers

H. Völler, A. Gitt, D. Pittrow, 2014, Clinical cardiology.

[Cardiovascular risk assessment by primary-care physicians in Germany and its lack of agreement with the Established Risk Scores (DETECT)].

S. Silber, H. Wittchen, A. Zeiher, 2008, Medizinische Klinik.

Interactions between rheumatologists and cardio-/pulmonologists in the assessment and use of outcome measures in pulmonary arterial hypertension related to systemic sclerosis.

M. Humbert, V. Strand, D. Furst, 2010, Clinical and experimental rheumatology.

Idiopathic pulmonary arterial hypertension phenotypes determined by cluster analysis from the COMPERA registry.

L. Harbaum, S. Rosenkranz, J. Behr, 2020, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Longitudinal change instead of baseline testosterone predicts depressive symptoms

S. Silber, W. März, H. Wittchen, 2018, Psychoneuroendocrinology.

Therapie der pulmonal arteriellen Hypertonie (PAH)

W. Haefeli, S. Rosenkranz, H. Ghofrani, 2010, Deutsche medizinische Wochenschrift.

Management and Outcomes of Patients with Isolated Superficial Vein Thrombosis under Real Life Conditions (INSIGHTS-SVT).

J. Klotsche, D. Pittrow, U. Hoffmann, 2021, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

Riociguat treatment in patients with chronic thromboembolic pulmonary hypertension: Final safety data from the EXPERT registry.

M. Humbert, J. Barberà, S. Rosenkranz, 2020, Respiratory medicine.

Risk assessment in medically treated chronic thromboembolic pulmonary hypertension patients

S. Rosenkranz, H. Klose, M. Hoeper, 2018, European Respiratory Journal.

The 6MWT as a prognostic tool in pulmonary arterial hypertension: results from the COMPERA registry

R. Ewert, D. Huscher, H. Klose, 2018, Clinical Research in Cardiology.

COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension

S. Rosenkranz, H. Ghofrani, R. Ewert, 2021, European Respiratory Journal.

Methods and Results—We analyzed data from Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA), an ongoing European pulmonary hypertension registry. Survival rates of patients with IPAH

R. Speich, S. Rosenkranz, H. Ghofrani, 2013 .

COMPERA Registry Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results from the

S. Rosenkranz, J. Behr, R. Ewert, 2013 .

Medical treatment of pulmonary hypertension in adults with congenital heart disease: updated and extended results from the International COMPERA-CHD Registry.

S. Rosenkranz, R. Ewert, D. Huscher, 2021, Cardiovascular diagnosis and therapy.

Measures of Response in Clinical Trials of Systemic Sclerosis: The Combined Response Index for Systemic Sclerosis (CRISS) and Outcome Measures in Pulmonary Arterial Hypertension Related to Systemic Sclerosis (EPOSS)

P. Tugwell, M. Mayes, P. Merkel, 2009, The Journal of Rheumatology.

Novel Insights into the Management of Patients with Very High Cardiovascular Risk Eligible for PCSK9 Inhibitor Treatment: Baseline Findings from the PERI-DYS Study.

U. Laufs, E. Steinhagen-Thiessen, J. Klotsche, 2022, Cardiovascular drugs and therapy.

International, Prospective Registry For The Documentation Of First-line And Maintenance Therapy In Patients With Pulmonary Hypertension (CompERA-XL): Aims, Design, Methods, And Baseline Characteristics Of Patients

H. Ghofrani, M. Hoeper, C. Vizza, 2010, ATS 2010.

Buprenorphine and methadone in the treatment of opioid dependence: methods and design of the COBRA study

F. Tretter, H. Wittchen, J. Klotsche, 2005, International journal of methods in psychiatric research.

Incidence and prevalence of pulmonary arterial hypertension in Germany.

M. Hoeper, D. Pittrow, D. Huscher, 2016, International journal of cardiology.

Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor.

D. Pittrow, R. Griebenow, E. Mueller, 1997, Blood pressure.

Different concepts in first-line treatment of essential hypertension. Comparison of a low-dose reserpine-thiazide combination with nitrendipine monotherapy. German Reserpine in Hypertension Study Group.

W. Kirch, D. Pittrow, G. Weidinger, 1997, Hypertension.

Therapie des Diabetes mellitus

D. Pittrow, 2003 .

Demographics, clinical characteristics, health resource utilization and cost of chronic thromboembolic pulmonary hypertension patients: retrospective results from six European countries

M. Hoeper, C. Vizza, D. Pittrow, 2014, BMC Health Services Research.

Ankle brachial index vs metabolic syndrome for risk prediction

H. Darius, D. Pittrow, C. Diehm, 2008, The Lancet.

High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes.

J. Allenberg, H. Darius, D. Pittrow, 2004, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Temporal trends in pulmonary arterial hypertension: results from the COMPERA registry

S. Rosenkranz, H. Ghofrani, R. Ewert, 2021, European Respiratory Journal.

Pulmonary vascular resistance predicts mortality in patients with pulmonary hypertension associated with interstitial lung disease: results from the COMPERA registry

S. Rosenkranz, M. Hoeper, K. Olsson, 2021, European Respiratory Journal.

Pulmonary hypertension in patients with chronic obstructive lung disease: results from COMPERA.

S. Rosenkranz, H. Ghofrani, R. Ewert, 2021, Chest.

Clinical outcomes of cancer-associated isolated superficial vein thrombosis in daily practice.

J. Klotsche, D. Pittrow, U. Hoffmann, 2022, Thrombosis Research.

[Importance of the ankle-brachial index (ABI) in the prevention of cardiovascular diseases. Ten questions and answers].

J. Allenberg, H. Darius, D. Pittrow, 2007, Herz.

Risk stratification and response to therapy in patients with pulmonary arterial hypertension and comorbidities: A COMPERA analysis.

S. Rosenkranz, H. Ghofrani, R. Ewert, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

Endothelin in human autoimmune diseases with renal involvement.

D. Pittrow, W. Neuhofer, 2006, Rheumatology.

Treatment of pulmonary arterial hypertension(PAH)

W. Haefeli, S. Rosenkranz, H. Ghofrani, 2010 .

High prevalence and poor control of hypertension in primary care: cross-sectional study

Peter Bramlage, Michael Höfler, Wilhelm Kirch, 2004, Journal of hypertension.

Drug interactions with angiotensin receptor blockers

W. Kirch, D. Pittrow, P. Bramlage, 2005, Expert opinion on drug safety.

The Effects of Venlafaxine on Cognitive Functions and Quantitative EEG in Healthy Volunteers

M. Siepmann, W. Kirch, M. Mueck‐Weymann, 2008, Pharmacopsychiatry.

Anticoagulation and Survival in Pulmonary Arterial Hypertension: Results From the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA)

R. Speich, S. Rosenkranz, J. Behr, 2013, Circulation.

1-Year outcomes of hypertension management in 13,000 outpatients under practice conditions: prospective 3A registry.

R. Schmieder, T. Riemer, J. Senges, 2014, International journal of cardiology.

The effect of irbesartan in reducing cardiovascular risk in hypertensive type 2 diabetic patients: an observational study in 16 600 patients in primary care

W. Kirch, D. Pittrow, P. Bramlage, 2004, Current medical research and opinion.

Mortality and Vascular Morbidity in Older Adults With Asymptomatic Versus Symptomatic Peripheral Artery Disease

Harald Darius, Ina Burghaus, J. Allenberg, 2009, Circulation.

Facilitated subcutaneous immunoglobulin use in pediatric patients with primary or secondary immunodeficiency diseases.

D. Pittrow, C. Hermann, U. Baumann, 2021, Immunotherapy.

Use of recombinant human hyaluronidase-facilitated subcutaneous immunoglobulin in elderly patients.

J. Klotsche, D. Pittrow, P. Paassen, 2020, Immunotherapy.

Therapeutic Advances in Neurological Disorders

R. Gold, C. Sommer, D. Huscher, 2014 .

Familial hypercholesterolemia in primary care in Germany. Diabetes and cardiovascular risk evaluation: Targets and Essential Data for Commitment of Treatment (DETECT) study.

W. März, M. Kleber, H. Scharnagl, 2016, Atherosclerosis.

Cardiovascular risk algorithms in primary care: Results from the DETECT study

S. Silber, W. März, U. Laufs, 2019, Scientific Reports.

Role of endothelin and endothelin receptor antagonists in renal disease

D. Pittrow, W. Neuhofer, 2006, European journal of clinical investigation.

Characterization, treatment patterns, and patient-related outcomes of patients with Fragile X syndrome in Germany: final results of the observational EXPLAIN-FXS study

D. Pittrow, M. Colla, M. Huss, 2016, BMC Psychiatry.

Psychiatrische und soziale Aspekte bei Patienten mit fragilem X-Syndrom (FRX)

D. Pittrow, M. Colla, M. Huss, 2015, Psychiatrische Praxis.

EXPLAIN Fragile-X: an explorative, longitudinal study on the characterization, treatment pathways, and patient-related outcomes of Fragile X Syndrome

D. Pittrow, M. Colla, M. Huss, 2013, BMC Psychiatry.

Abuse and dependence potential for the non-benzodiazepine hypnotics zolpidem and zopiclone: a review of case reports and epidemiological data.

W. Kirch, H. Wittchen, G. Hajak, 2003, Addiction.

Determinants of lipid goal achievement in patients on extended-release nicotinic acid/laropiprant in primary care clinical practice

E. Steinhagen-Thiessen, D. Pittrow, S. Hildemann, 2013, Current medical research and opinion.

Cardiovascular Parameters during Submaximal Exercise following Submucous Administration of Articaine

W. Kirch, D. Pittrow, C. Schindler, 2003, Clinical drug investigation.

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care

A. Goette, D. Pittrow, G. Benninger, 2015, Herzschrittmachertherapie + Elektrophysiologie.

Atrial fibrillation management, outcomes and predictors of stable disease in daily practice: prospective non-interventional study.

S. Willich, W. Kirch, D. Pittrow, 2013, International journal of cardiology.

Management of atrial fibrillation by primary care physicians in Germany: baseline results of the ATRIUM registry

P. Kirchhof, S. Willich, W. Kirch, 2011, Clinical Research in Cardiology.

Presentation of atrial fibrillation and its management by cardiologists in the ambulatory and hospital setting: MOVE cross-sectional study

S. Willich, W. Kirch, D. Pittrow, 2011, Current medical research and opinion.

Economic burden of patients with various etiologies of chronic systolic heart failure analyzed by resource use and costs.

R. Wachter, V. Regitz-Zagrosek, R. Erbel, 2012, International journal of cardiology.

Resource use and costs in systolic heart failure according to disease severity: a pooled analysis from the German Competence Network Heart Failure

R. Wachter, V. Regitz-Zagrosek, R. Erbel, 2012, Journal of Public Health.

Extended‐release niacin/laropiprant for lipid management: observational study in clinical practice

E. Steinhagen-Thiessen, D. Pittrow, S. Hildemann, 2013, International journal of clinical practice.

Pulmonary hypertension in adults with congenital heart disease: First data from Latvian PAH registry.

C. Kropf-Sanchen, G. Hansmann, S. Rosenkranz, 2016, European journal of internal medicine.

High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study.

J. Allenberg, H. Darius, D. Pittrow, 2004, Atherosclerosis.

Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials

Ami A. Shah, R. Hubbard, W. Dixon, 2013, Thorax.

Systemic sclerosis - continuing progress in developing clinical measures of response.

P. Merkel, V. Strand, D. Furst, 2007, The Journal of rheumatology.

Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long‐term data of the SIGNS study

R. Gold, C. Sommer, D. Huscher, 2017, European journal of haematology.

Cardiovascular risk factors in primary care: methods and baseline prevalence rates – the DETECT program

S. Silber, W. März, H. Wittchen, 2005, Current medical research and opinion.

Inhibition of endothelin receptors in the treatment of pulmonary arterial hypertension: does selectivity matter?

W. Kirch, R. Ewert, C. Opitz, 2008, European heart journal.

A. Prasse, T. Welte, F. Herth, 2017, Respiratory Research.

[Characteristics and management of idiopathic pulmonary fibrosis: INSIGHTS-IPF registry].

M. Kreuter, M. Hoeper, J. Klotsche, 2012, Deutsche medizinische Wochenschrift.

The DETECT adherence score – structure and psychometric exploration of a novel approach to measure adherence to drug and non‐drug interventions in primary care

H. Wittchen, D. Leistner, J. Klotsche, 2011, International journal of methods in psychiatric research.

Prevalence of anemia in elderly patients in primary care: impact on 5-year mortality risk and differences between men and women

D. Pittrow, C. Diehm, H. Trampisch, 2009 .

Defining appropriate outcome measures in pulmonary arterial hypertension related to systemic sclerosis: a Delphi consensus study with cluster analysis.

Oliver Distler, Peter Nash, Marc Humbert, 2008, Arthritis and rheumatism.

Reproducibility and reliability of the ankle—brachial index as assessed by vascular experts, family physicians and nurses

T. Holland-Letz, J. Kunert, Stefanie Biedermann, 2007, Vascular medicine.

Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled.

Arya M. Sharma, W. Kirch, H. Wittchen, 2004, American journal of hypertension.

Management and outcomes of patients with reduced ejection fraction after acute myocardial infarction in cardiac rehabilitation centers

H. Völler, A. Gitt, D. Pittrow, 2015, Current medical research and opinion.

HYDRA: possible determinants of unsatisfactory hypertension control in German primary care patients

M. Höfler, Arya M. Sharma, W. Kirch, 2004, Blood pressure.

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry

K. Bestehorn, A. Gitt, D. Pittrow, 2013, Vascular health and risk management.

Effect of guideline orientation on the outcomes of peripheral arterial disease in primary care

U. Siebert, O. Ommen, H. Pfaff, 2011, Current medical research and opinion.

Atherogenic dyslipidemia as evidenced by the lipid triad: prevalence and associated risk in statin-treated patients in ambulatory care

G. Assmann, H. Schulte, K. Bestehorn, 2010, Current medical research and opinion.

Outcomes of medical management of peripheral arterial disease in general practice: follow-up results of the PACE-PAD Study

U. Siebert, O. Ommen, H. Pfaff, 2010, Journal of Public Health.

Management of patients with peripheral arterial disease in primary care: a cross‐sectional study in Germany

D. Pittrow, K. Kröger, C. Diehm, 2010, International journal of clinical practice.

S. Willich, W. Kirch, D. Pittrow, 2010, Deutsche medizinische Wochenschrift.

Pre-Capillary, Combined, and Post-Capillary Pulmonary Hypertension: A Pathophysiological Continuum.

S. Rosenkranz, M. Hoeper, K. Olsson, 2016, Journal of the American College of Cardiology.

High prevalence of peripheral arterial disease but low antiplatelet treatment rates in elderly primary care patients with diabetes.

J. Allenberg, H. Darius, D. Pittrow, 2003, Diabetes care.

Improved risk stratification in prevention by use of a panel of selected circulating microRNAs

S. Silber, U. Völker, S. Baumeister, 2017, Scientific Reports.

Atorvastatin treatment and LDL cholesterol target attainment in patients at very high cardiovascular risk

U. Laufs, D. Pittrow, B. Karmann, 2016, Clinical Research in Cardiology.

Management of Patients With Atrial Fibrillation by Primary‐Care Physicians in Germany: 1‐Year Results of the ATRIUM Registry

P. Kirchhof, W. Kirch, T. Meinertz, 2014, Clinical cardiology.

Prognostic value of a low post-exercise ankle brachial index as assessed by primary care physicians.

J. Allenberg, H. Darius, D. Pittrow, 2011, Atherosclerosis.

Echocardiography as an Outcome Measure in Scleroderma-related Pulmonary Arterial Hypertension: A Systematic Literature Analysis by the EPOSS Group

M. Humbert, V. Strand, D. Furst, 2010, The Journal of Rheumatology.

Echocardiography as an outcome measure in scleroderma-related pulmonary arterial hypertension Results of a systematic literature analysis by the EPOSS group

M. Humbert, V. Strand, D. Furst, 2010 .

Risk assessment in pulmonary arterial hypertension

M. Humbert, S. Rosenkranz, O. Sitbon, 2018, European Respiratory Journal.

Prevalence, recognition and management of depression in primary care in Germany: the Depression 2000 study

H. Wittchen, D. Pittrow, 2002, Human psychopharmacology.

[NISAS-2000: The "Nationwide Insomnia Screening and Awareness Study". Prevalence and interventions in primary care].

M. Höfler, H. Wittchen, G. Hajak, 2001, Fortschritte der Medizin. Originalien.

Aliskiren/amlodipine as a single-pill combination in hypertensive patients: subgroup analysis of elderly patients, with metabolic risk factors or high body mass index

D. Pittrow, C. Sieder, E. Kaiser, 2012, Journal of drug assessment.

Raucherentwöhnung in der primärärztlichen Versorgung: Ziele, Design und Methoden der "Smoking and Nicotine Dependence Awareness and Screening (SNICAS)"-Studie

M. Höfler, D. Pittrow, H. Wittchen, 2012 .

Aims, design and methods of the Smoking and Nicotine Dependence Awareness and Screening (SNICAS) study

H. Wittchen, D. Pittrow, E. Hoch, 2003, International journal of methods in psychiatric research.

Changes in the Prevalence, Treatment and Control of Hypertension in Germany? A Clinical-Epidemiological Study of 50.000 Primary Care Patients

Martin Wehling, Winfried März, Hendrik Lehnert, 2012, PloS one.

[Cardiovascular high-risk constellations in primary care. DETECT Study 2003].

S. Silber, W. März, H. Wittchen, 2005, Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz.

Patterns of antihypertensive drug utilization in primary care

M. Höfler, Arya M. Sharma, W. Kirch, 2004, European Journal of Clinical Pharmacology.

[Aim, design and methods of the "Hypertension and diabetes screening and awareness" -- (HYDRA) study].

M. Höfler, W. Kirch, H. Wittchen, 2003, Fortschritte der Medizin. Originalien.

Unmet needs in the diagnosis and treatment of dyslipidemia in the primary care setting in Germany.

S. Silber, H. Scharnagl, H. Wittchen, 2007, Atherosclerosis.

Improved Detection of Paroxysmal Atrial Fibrillation Utilizing a Software-Assisted Electrocardiogram Approach

D. Pittrow, L. Rosin, Ludger Rosin, 2014, PloS one.

Predictors of uncontrolled hyperlipidaemia in high-risk ambulatory patients in primary care

C. Bode, H. Darius, D. Pittrow, 2008, Current medical research and opinion.

Regression of Microalbuminuria in Type 2 Diabetics after Switch to Irbesartan Treatment

W. Kirch, H. Lehnert, D. Pittrow, 2004, Clinical drug investigation.

Types and outcomes of cardioversion in patients admitted to hospital for atrial fibrillation: results of the German RHYTHM-AF Study

A. Gitt, D. Pittrow, T. Lewalter, 2013, Clinical Research in Cardiology.

Are elevated homocysteine plasma levels related to peripheral arterial disease? Results from a cross‐sectional study of 6880 primary care patients

J. Allenberg, H. Darius, D. Pittrow, 2003, European journal of clinical investigation.

Evaluation of the Efficacy and Tolerability of a Low-Dose Combination of Isradipine and Spirapril in the First-Line Treatment of Mild to Moderate Essential Hypertension

D. Pittrow, G. Wambach, G. Weidinger, 1997, Cardiovascular Drugs and Therapy.

Exacerbations, hospitalisations and mortality in patients with idiopathic pulmonary fibrosis in clinical practice: INSIGHTS-IPF registry

A. Prasse, T. Welte, J. Behr, 2017 .

Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry

R. Gold, C. Sommer, D. Huscher, 2016, Therapeutic advances in neurological disorders.

Accuracy of anthropometric indicators of obesity to predict cardiovascular risk.

Winfried März, Hendrik Lehnert, Heide Glaesmer, 2007, The Journal of clinical endocrinology and metabolism.

Testosterone is not associated with traits of optimism or pessimism: Observational evidence from the prospective DETECT study

J. Hoyer, S. Silber, W. März, 2018, PloS one.

Novel insights into the management of German patients with very high cardiovascular risk eligible for PCSK9 inhibitor treatment: baseline characteristics from the PERI-DYS study

U. Laufs, E. Steinhagen-Thiessen, J. Klotsche, 2021, European Heart Journal.

The role of gender and anxiety in the association between somatic diseases and depression: findings from three combined epidemiological studies in primary care

H. Wittchen, H. Wittchen, K. Beesdo-Baum, 2017, Epidemiology and Psychiatric Sciences.

Pattern of prescriptions issued by nursing home‐based physicians versus office‐based physicians for frail elderly patients in German nursing homes

W. Kirch, D. Pittrow, I. Hach, 2003, Pharmacoepidemiology and drug safety.

Gender differences in patients with atrial fibrillation

W. Kirch, D. Pittrow, H. Bonnemeier, 2013, Herzschrittmachertherapie + Elektrophysiologie.

Treatment patterns, risk factor control and functional capacity in patients with cardiovascular and chronic kidney disease in the cardiac rehabilitation setting

H. Völler, A. Gitt, D. Pittrow, 2014, European journal of preventive cardiology.

Improved prediction of all-cause mortality by a combination of serum total testosterone and insulin-like growth factor I in adult men

H. Völzke, W. März, H. Wittchen, 2012, Steroids.

Immunoglobulins for primary or secondary immunodeficiency or for immunomodulation in neurological autoimmune diseases: insights from the prospective SIGNS registry

W. Kirch, R. Gold, D. Huscher, 2012, Journal of Public Health.

Treatment of Neurological Autoimmune Diseases with Immunoglobulins: First Insights from the Prospective SIGNS Registry

W. Kirch, R. Gold, D. Huscher, 2012, Journal of Clinical Immunology.

[Assessment of immunoglobulins in a long-term non-interventional study (SIGNS Study). Rationale, design, and methods].

W. Kirch, R. Gold, D. Huscher, 2010, Medizinische Klinik.

Impact of a Low-Dose Combination of Isradipine SRO and Spirapril on Left Ventricular Mass and Left Ventricular Performance in Patients with Hypertension and Left Ventricular Hypertrophy

D. Pittrow, T. Stoerk, H. Eichstaedt, 2002 .

Frequency of albuminuria in primary care: a cross-sectional study

M. Höfler, W. Kirch, H. Wittchen, 2007, European journal of cardiovascular prevention and rehabilitation : official journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology.

Recognition and management of overweight and obesity in primary care in Germany

S Dahm, M. Höfler, W. Kirch, 2004, International Journal of Obesity.

Analgesic Efficacy of Flupirtine in Primary Care of Patients with Osteoporosis Related Pain

K. Wegscheider, D. Pittrow, J. Ringe, 2003, Arzneimittelforschung.

Metoprolol Succinate SR plus Hydrochlorothiazide (Beloc-Zok® Comp) in Patients with Essential Hypertension in General Practice

D. Pittrow, S. Hildemann, Fischer Hm, 2002 .

Hypertension and diabetes care among primary care doctors in Germany: results from an epidemiological cross-sectional study

W. Kirch, H. Wittchen, D. Pittrow, 2004 .

Risiken der Koronaräquivalente Diabetes mellitus und Periphere Arterielle Verschlusskrankheit im Vergleich

J. Allenberg, H. Darius, D. Pittrow, 2008, Deutsche medizinische Wochenschrift.

Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany

A. Gitt, D. Pittrow, F. Sonntag, 2016, Current medical research and opinion.